Bio-Rad Laboratories (BIO) Receivables - Other (2013 - 2026)

Bio-Rad Laboratories (BIO) has reported Receivables - Other for 10 consecutive years, with $8.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Other rose 9.88% year-over-year to $8.9 million in Q2 2026; TTM through Jun 2026 was $8.9 million, a 9.88% increase from a year earlier, with the FY2025 full-year figure at $11.9 million, down 9.16% from the prior year.
• Receivables - Other was $8.9 million for Q2 2026 at Bio-Rad Laboratories, down from $13.3 million in the prior quarter.
• Over five years, Receivables - Other peaked at $14.8 million in Q1 2023 and troughed at $6.3 million in Q2 2022.
• A 5-year average of $10.8 million and a median of $11.2 million in 2023 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other jumped 427.27% in 2022 and decreased 17.35% in 2025, its largest moves.
• Over 5 years, Receivables - Other stood at $11.6 million in 2022, then increased by 2.59% to $11.9 million in 2023, then advanced by 10.08% to $13.1 million in 2024, then slipped by 9.16% to $11.9 million in 2025, then retreated by 25.21% to $8.9 million in 2026.
• The last three Receivables - Other figures came in at $8.9 million (Q2 2026), $13.3 million (Q1 2026), and $11.9 million (Q4 2025), per Business Quant data.